| Position statement | Class | References |
|---|---|---|
| A careful review of device memories is required at each follow-up of patients with CIEDs. |  | 17 |
| Risk stratification to identify individuals that require further investigation aimed at establishing AF diagnosis should be performed using the CHA2DS2-VASc score in patients with SCAF/AHREs (>5 min) | | 86 |
| Intensified follow-up, eventually using remote monitoring, is justifiable in patients with AHREs <24 h in individuals at risk of thromboembolic episodes. | | 87 |
| Based on their risk stratification, initiation of oral anticoagulation may be an option in patients with SCARF/AHREs lasting longer than 24 h. |  | 65 |
| No anticoagulation is needed in patients when asymptomatic atrial tachyarrhythmias lasting <5 min are discovered in device memories of CIEDs. |  | 10,75,82,85 |
| Position statement | Class | References |
|---|---|---|
| A careful review of device memories is required at each follow-up of patients with CIEDs. | | 17 |
| Risk stratification to identify individuals that require further investigation aimed at establishing AF diagnosis should be performed using the CHA2DS2-VASc score in patients with SCAF/AHREs (>5 min) | | 86 |
| Intensified follow-up, eventually using remote monitoring, is justifiable in patients with AHREs <24 h in individuals at risk of thromboembolic episodes. | | 87 |
| Based on their risk stratification, initiation of oral anticoagulation may be an option in patients with SCARF/AHREs lasting longer than 24 h. | | 65 |
| No anticoagulation is needed in patients when asymptomatic atrial tachyarrhythmias lasting <5 min are discovered in device memories of CIEDs. | | 10,75,82,85 |
| Position statement | Class | References |
|---|---|---|
| A careful review of device memories is required at each follow-up of patients with CIEDs. | | 17 |
| Risk stratification to identify individuals that require further investigation aimed at establishing AF diagnosis should be performed using the CHA2DS2-VASc score in patients with SCAF/AHREs (>5 min) | | 86 |
| Intensified follow-up, eventually using remote monitoring, is justifiable in patients with AHREs <24 h in individuals at risk of thromboembolic episodes. | | 87 |
| Based on their risk stratification, initiation of oral anticoagulation may be an option in patients with SCARF/AHREs lasting longer than 24 h. | | 65 |
| No anticoagulation is needed in patients when asymptomatic atrial tachyarrhythmias lasting <5 min are discovered in device memories of CIEDs. | | 10,75,82,85 |
| Position statement | Class | References |
|---|---|---|
| A careful review of device memories is required at each follow-up of patients with CIEDs. | | 17 |
| Risk stratification to identify individuals that require further investigation aimed at establishing AF diagnosis should be performed using the CHA2DS2-VASc score in patients with SCAF/AHREs (>5 min) | | 86 |
| Intensified follow-up, eventually using remote monitoring, is justifiable in patients with AHREs <24 h in individuals at risk of thromboembolic episodes. | | 87 |
| Based on their risk stratification, initiation of oral anticoagulation may be an option in patients with SCARF/AHREs lasting longer than 24 h. | | 65 |
| No anticoagulation is needed in patients when asymptomatic atrial tachyarrhythmias lasting <5 min are discovered in device memories of CIEDs. | | 10,75,82,85 |
